Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage

Sci Rep. 2016 Aug 23:6:31916. doi: 10.1038/srep31916.

Abstract

Reliable test systems to identify hepatotoxicity are essential to predict unexpected drug-related liver injury. Here we present a human ex-vivo liver model to investigate acetaminophen-induced liver injury. Human liver tissue was perfused over a 30 hour period with hourly sampling from the perfusate for measurement of general metabolism and clinical parameters. Liver function was assessed by clearance of indocyanine green (ICG) at 4, 20 and 28 hours. Six pieces of untreated human liver specimen maintained stable liver function over the entire perfusion period. Three liver sections incubated with low-dose acetaminophen revealed strong damage, with ICG half-lives significantly higher than in non-treated livers. In addition, the release of microRNA-122 was significantly higher in acetaminophen-treated than in non-treated livers. Thus, this model allows for investigation of hepatotoxicity in human liver tissue upon applying drug concentrations relevant in patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / adverse effects*
  • Aged
  • Biomarkers / metabolism
  • Chemical and Drug Induced Liver Injury / genetics
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / physiopathology*
  • DNA, Mitochondrial / drug effects
  • DNA, Mitochondrial / genetics
  • Female
  • Humans
  • Liver Function Tests
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Models, Biological*
  • Up-Regulation

Substances

  • Biomarkers
  • DNA, Mitochondrial
  • MIRN122 microRNA, human
  • MicroRNAs
  • Acetaminophen